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deviate more than ~2 mm from the gating window center. 
Log files provided the transponder motion during beam-on in 
the actual gated treatments and in simulated non-gated 
treatments with CBCT-guided patient setup. This motion was 
used to reconstruct the actually delivered CTV dose 
distribution with gating and the would-be dose distribution 
without gating. The minimum dose to 95% of the CTV (D95) 
for each fraction and each course was compared with the 
planned CTV D95. 
 
Results: Fig. A shows the internal tumor motion at a fraction 
with large baseline drift of 3mm (LR), 9mm (CC), and 6mm 
(AP) relative to the pre-treatment CBCT. Fig. B shows the 
same motion with four drift compensating couch adjustments 
applied as marked with red lines. The width of the green 
areas indicates the time of beam delivery. The height 
indicates the allowed positions for beam-on without (Fig. A) 
and with (Fig. B) gating. The course mean geometrical error 
was <1.2mm for all gated treatments, but would have ranged 
from -2.8mm to 1.2mm (LR), from 0.7mm to 7.1mm (CC), 
and from -2.6mm to 0.1mm (AP) without gating due to 
baseline drift. Fig. C shows the CTV D95 reduction relative to 
the planned D95 versus the 3D mean error for each fraction 
and course. The mean reduction in D95 for the 12 fractions 
was 1.1% [range: 0.1-2.1%] with gating and 10.8% [0.9-35%] 
without gating. The mean duty cycle was 59% [54-70%]. 
 
 
 
Conclusion: Respiratory gating based on internal 
electromagnetic monitoring was performed for four liver 
SBRT patients. The gating added robustness to the dose 
delivery and ensured a high CTV dose even in the presence of 
large intrafraction motion. 
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Purpose or Objective: Ablative radiotherapy is rapidly 
emerging as an effective treatment for locally advanced 
pancreatic adenocarcinoma. However, the pancreas 
undergoes erratic and unstable respiratory-induced motion, 
which decreases coverage of the tumor and increases dose to 
the duodenum. The purpose of this study was to develop and 
optimize motion management protocols which allow for safe 
delivery of pancreatic SBRT. 
 
Material and Methods: We analyzed 4DCT and CBCT data 
from 35 patients who received pancreatic SBRT; the majority 
were locally advanced tumors receiving 30 Gy in 5 fractions. 
In total, the data from 175 treated fractions was analyzed. 
For each fraction, the daily trajectory of the tumor was 
reconstructed by calculating a Gaussian probability density 
function using the location of gold fiducial markers in the 
CBCT projections. These trajectories represented over 600 
samples of the position of the tumor during the course of 
CBCT acquisition. Using the calculated trajectories, we 
investigated the dosimetric impact of several respiratory 
motion management strategies, including gating based on 
instantaneous kV imaging of implanted fiducial markers. 
 
Results: 4DCT was a poor predictor of pancreatic motion, as 
the amplitude of daily motion exceeded the predictions of 
pre-treatment 4DCT by an average of 3.5 mm in the SI 
direction. In a Fourier-based analysis, these uncertainties 
were correlated with an increase in low-frequency motion 
(potentially due to peristalsis of the duodenum). Abdominal 
compression increased the consistency of motion and reduced 
the amplitude by 2.7 ± 2.8 mm. On average, respiratory 
gating decreased the apparent motion even further, with 
attainable effective motion amplitudes of 2 mm. However, 
gating based on external surrogates (either phase- or 
amplitude-based) is greatly hindered in some patients by the 
inconsistency of pancreatic motion. In these cases, internal 
gating surrogates are warranted. In a simulated clinical 
scenario, fiducial-based internal gating using a 2 mm SI 
window greatly outperformed conventional gating using 
external surrogates (p<0.001), with a mean target D95 of 
99±2%, 95% CI 93-100% (conventional gating – D95 97±7%, 95% 
CI 68-100%). Additionally, we analyzed the dosimetry of 
motion by convolving the dose distribution with phase-
specific motion information. Using these data, we developed 
a metric that predicts patient-specific consistency, and in a 
simulated adaptive protocol which adjusted margins based on 
this metric, there were significant increases in mean target 
D95 and minimum dose. 
 
Conclusion: Motion management is essential in reducing the 
size of target volumes and minimizing dose/side effects to 
the small bowel. Motion uncertainties and patient-specific 
differences warrant an adaptive approach to respiratory 
management. Our data shows that using real-time kV imaging 
of implanted fiducial markers to adapt the gating protocol 
based on the instantaneous position of the tumor 
outperforms conventional approaches. 
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Purpose or Objective: PROMETHEUS (UTN: U1111-1167-2997) 
is a multicentre clinical trial investigating the feasibility of 
stereotactic radiotherapy (SBRT) as a boost technique for 
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prostate cancer. The objective of this sub-study is to 
evaluate infraction motion, using cine MRI, and the 
dosimetric impact when using a rectal immobilisation device 
(RID). 
 
Material and Methods: The initial 10 patients recruited 
underwent planning CT and MRI, with and without a RID. Cine 
MRI images were captured using an interleaved T2 HASTE 
sequence in sagittal and axial planes with a temporal 
resolution of 5.4 seconds acquired over 4 minutes, the 
average time for a single SBRT VMAT fraction. Points of 
interest (POI) were outlined by a single investigator and a 
validated tracking algorithm measured displacement of these 
points over the 4 minutes in the anterior – posterior, superior 
– inferior and left – right directions (Figure 1). 
 
 
 
Planning CT and MRI scans were fused and contoured by a 
single investigator. They were planned using a VMAT 
technique to 19Gy in 2 fractions by a single investigator. The 
planning priority set for the non – RID plan was to match the 
coverage achieved in the RID plan. Dose Volume Histogram 
results of both plans were analysed. 
 
Results: There was an overall trend for increasing POI 
displacement in all directions as time progressed when no RID 
was insitu. POI remained comparatively stable with the RID.  
In the sagittal plane, the RID resulted in statistically 
significant improvement in the range of anterior - posterior 
displacement over the entire 4 minutes of the inferior 
anterior and posterior rectal wall (both p <0.001), mid 
anterior and posterior rectal wall (both p = 0.007), anterior 
prostate (p =0.019), prostate apex (p = 0.003) and prostate 
base (p=0.011).  
The RID also resulted in improvement in range of superior - 
inferior displacement of the inferior posterior rectal wall (p = 
0.002), mid anterior rectal wall (p = 0.043) and posterior 
rectal wall (p = 0.023).  
In the axial plane, the RID resulted in statistically significant 
improvement in the range of anterior - posterior 
displacement of the anterior rectal wall (p =0.008) and 
posterior prostate (p=0.011).  
For all these points, the RID approximately halved the range 
of displacements, with some points moving over 2mm when 
no RID was insitu. 
Dosimetrically, the use of a RID significantly reduced rectal 
V16 (0.27cc vs 1.71cc; p < 0.001), V14 (1.12cc vs 2.32cc; p 
=0.02) and Dmax (15.72Gy vs 18.90Gy; p < 0.001), as well as 
percentage of posterior rectal wall receiving 8.5Gy (7.38% vs 
12.20%; p = 0.003). There was no statistically significant 
difference between bladder or urethral Dmax, CTV D98 or 
conformity index between both plans. 
 
Conclusion: The rectal immobilisation device used in 
stereotactic prostate radiotherapy leads to reduced 
intrafraction motion of the prostate and rectum, with 
increasing improvement with time. It also results in 
significant improvement in rectal wall dosimetry. 
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Purpose or Objective: The purpose of this study was to 
analyze the modulation indexes proposed in the literature for 
predicting interplay effects in lung SABR treatments 
 
Material and Methods: 23 SABR plans (4 arcs of 200°-220° for 
6MV and 2 arcs for 10 MV FFF) calculated on Eclipse V10.1 
(Varian) were analyzed with the Quasar respiratory phantom 
(Modus Medical Devices) by comparing dose distributions on 
EBT3 radiochromic film. Static and dynamic irradiation at 0.5 
cm amplitude (1 cm peak-to-peak) and 12 breaths per minute 
(BPM) was used. 18 plans were irradiated in a Silouette LINAC 
with 6 MV and 5 on a TrueBeam (Varian) LINAC with 6 MV 
FFF. The acceptance criteria was set to be < 5% of points 
with γ( 3%,3mm )>1 on the comparison between static and 
dynamic dose distributions. A threshold of 90% was fixed 
since the aim was to study the influence of the modulation 
on the ITV. The modulation indexes analyzed were: The 
Modulation Complexity Score (MCS)-McNiven 2010; the 
Modulation Index Total (MIt)- Park 2014 which introduces 
speed and MLC acceleration and finally the Aperture 
Irregularity (AI) -Du 2014 which analyzes the non-circularity 
of the MLC apertures. A Matlab (Mathworks) program was 
developed to calculate them. Finally, the PUMA method, 
which is based on splitting arcs in the TPS and modeling 
movements by changing their isocenter positions, was also 
used. Possible linear correlation between these indexes and 
radiochromic films was analyzed and a statistical analysis 
performed. 
 
Results: Modulation indexes are shown in Table 1. A 
statistical analysis of the goodness of fit was done; which 
found only significant linear correlation (p < 0.0001) between 
film-PUMA, film-MIt and also between PUMA-MIt A positive 
plan is considered to be a plan suitable for treatment when 
evaluating the interplay effect. A value of 0.6 for the MIt 
index is proposed as the upper limit. This value was selected 
in order to minimize the number of false negative plans. MIt 
and PUMA have the same specificity (100%) since both 
detected all of the failing plans. However, PUMA has a 
greater sensitivity (95% vs 85%). 
